|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.330 SEK | -5.34% |
|
-1.42% | -38.30% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 92.22M 9.57M 8.36M 7.72M 7.11M 13.41M 921M 13.7M 36.27M 451M 35.93M 35.14M 1.55B | P/E 2026 * |
-2.72x | P/E 2027 * | -1.99x |
|---|---|---|---|---|---|
| Enterprise Value | 84.22M 8.74M 7.64M 7.05M 6.5M 12.24M 842M 12.51M 33.13M 412M 32.82M 32.1M 1.42B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -5.34% | ||
| 1 week | -1.42% | ||
| Current month | -2.00% | ||
| 1 month | -5.34% | ||
| 3 months | +5.98% | ||
| 6 months | -21.42% | ||
| Current year | -38.30% |
| 1 week | 8.25 |  | 8.9 |
| 1 month | 8 | | 9.18 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 319 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/3/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/3/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.34% | -1.42% | -64.55% | -68.74% | 9.57M | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.64% | +0.34% | +18.86% | +43.37% | 357.51B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.22M -2.81M -2.59M -2.39M -4.51M -310M -4.61M -12.19M -152M -12.08M -11.81M -522M | -46M -4.77M -4.17M -3.85M -3.55M -6.69M -460M -6.83M -18.09M -225M -17.92M -17.53M -775M |
| Net Debt | -8M -830K -725K -669K -617K -1.16M -79.93M -1.19M -3.15M -39.15M -3.12M -3.05M -135M | -10M -1.04M -907K -837K -771K -1.45M -99.91M -1.49M -3.93M -48.93M -3.9M -3.81M -168M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | SEK 8.330 | -5.34% | 7,339 |
| 16/07/26 | SEK 8.800 | +6.02% | 5,702 |
| 15/07/26 | SEK 8.300 | -4.82% | 3,537 |
| 14/07/26 | SEK 8.720 | +3.32% | 4,907 |
| 13/07/26 | SEK 8.440 | -0.12% | 13,974 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
